TLR4型
TRPV4型
炎症
凝血酶
细胞生物学
受体
信号转导
Toll样受体
TLR2型
蛋白酶激活受体2
化学
免疫学
生物
瞬时受体电位通道
先天免疫系统
酶联受体
生物化学
血小板
作者
Sheikh Rayees,Jagdish Chandra Joshi,Mohammad Tauseef,Mumtaz Anwar,Sukriti Baweja,Ian Rochford,Brijendra Kumar Joshi,Morley D. Hollenberg,Sekhar P. Reddy,Dolly Mehta
出处
期刊:Cell Reports
[Cell Press]
日期:2019-04-01
卷期号:27 (3): 793-805.e4
被引量:50
标识
DOI:10.1016/j.celrep.2019.03.053
摘要
Alveolar macrophages (AMs), upon sensing pathogens, trigger host defense by activating toll-like receptor 4 (TLR4), but the counterbalancing mechanisms that deactivate AM inflammatory signaling and prevent lethal edema, the hallmark of acute lung injury (ALI), remain unknown. Here, we demonstrate the essential role of AM protease-activating receptor 2 (PAR2) in rapidly suppressing inflammation to prevent long-lasting injury. We show that thrombin, released during TLR4-induced lung injury, directly activates PAR2 to generate cAMP, which abolishes Ca2+ entry through the TRPV4 channel. Deletion of PAR2 and thus the accompanying cAMP generation augments Ca2+ entry via TRPV4, causing sustained activation of the transcription factor NFAT to produce long-lasting TLR4-mediated inflammatory lung injury. Rescuing thrombin-sensitive PAR2 expression or blocking TRPV4 activity in PAR2-null AMs restores their capacity to resolve inflammation and reverse lung injury. Thus, activation of the thrombin-induced PAR2-cAMP cascade in AMs suppresses TLR4 inflammatory signaling to reinstate tissue integrity.
科研通智能强力驱动
Strongly Powered by AbleSci AI